MIAMI–(BUSINESS WIRE)–DermaSensor Inc. – Skin cancer is a global health concern, with increasing incidence rates worldwide. Artificial Intelligence (AI) is expanding its presence within dermatology with several tools available abroad, although no skin cancer AI …
New Study of an AI-Powered Spectroscopy Device Shows Promise for Skin Cancer Detection Read More »
Health Technology Executives Steve Meyer, ex-Pres/CEO of Welch Allyn, and Jason Bellet, Co-Founder/Board Member of Eko Health, join Commercial Advisory Board MIAMI, September 25, 2023, EINPresswire.com — a leader in the field of non-invasive skin …
DermaSensor Bolsters Leadership Team And Commercial Advisory Board Read More »
Presented at the 2023 American Academy of Dermatology Innovation Academy, the findings demonstrate the potential for DermaSensor’s device to help detect skin cancer across a range of skin types MIAMI, August 10, 2023, Business Wire …
DermaSensor’s Device with FDA Breakthrough Designation Demonstrated 96.2% Sensitivity for Detecting Melanoma in Patients Aged 65 and Older MIAMI, July 13, 2023, Business Wire — DermaSensor Inc., a health technology company equipping primary care physicians …
MIAMI, May 9, 2023, EINPresswire.com — DermaSensor Inc. is pleased to announce that it is a winner in the 2023 MedTech Breakthrough Awards program for its innovative, non-invasive device that better equips primary care physicians …
